Dr. Stephanie Schorge

• 1999 – 2004
  Postdoctoral Researcher; Department of Pharmacology, UCL
  
  

• 2005
  Senior Postdoctoral Researcher; UCL Institute of Neurology
  
  

• 2005 – 2010
  Pewterers’ Fellow; UCL Institute of Neurology
  
  

• 2010 – 2013
  Senior Research fellow; Royal Society University Research Fellow; UCL Institute of Neurology
  
  

• since 2013
  Principal Research Fellow; Royal Society University Research Fellow; UCL Institute of Neurology
  
  

• Wykes, R.C., Heeroma, J.H., Mantoan, L., Zheng, K., MacDonald, D.C., Deisseroth, K., ...Schorge, S., Kullmann, D.M. (2012). Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy.. Science Translational Medicine, 4 (161), doi:10.1126/scitranslmed.3004190

• Fletcher, E.V., Kullmann, D.M., Schorge, S. (2011). Alternative splicing modulates inactivation of type 1 voltage-gated sodium channels by toggling an amino acid in the first S3-S4 linker.. J BIOL CHEM, 286 (42), 36700-36708. doi:10.1074/jbc.M111.250225

• EpimiRNA

• Synaptopathies

• Member Society for Neuroscience

• Member of Science advisory Committee for Epilepsy Research UK

• Member of the UK Science advisory Committee for Genetically Modified Organisms (contained use)

• Gene therapy for Epilepsy: http://www.bbc.co.uk/news/health-20297386 and http://www.thenakedscientists.com/HTML/interviews/interview/1000024/

Additional interests

• implementation of 3Rs

• regulation of genetically modified organisms

You can only see the contact information of the academics in the database if you are a registered user of AcademiaNet.
Please register here